Mettler Toledo (MTD)

NYSE Health Care Life Sciences Tools & Services S&P 500
$1,722.15
+43.07 (+2.57%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 05)
$12.57 vs $12.11 est.
Surprise +3.8%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 05, 2026Sep/2026$12.11$12.57+3.8%

Our record of MTD's reports since we began tracking; it grows each quarter.

Latest results, in brief

All MTD 8-K briefs →
Nov 5, 4:33 PM ET

Mettler-Toledo Reports Third Quarter 2026 Results and Raises Full-Year Guidance

Positive earnings 2.02

Mettler-Toledo International Inc. reported third quarter 2026 net sales of $1.094 billion, representing a 6% increase compared to the prior-year period. Diluted earnings per share rose to $12.29 from $10.57, while adjusted EPS grew 13% to $12.57, driven by improving market demand and solid execution. Management also raised its full-year 2026 adjusted EPS guidance range to $47.70 to $47.90.

  • Reported net sales for the third quarter of 2026 increased 6% to $1.094 billion.
  • Diluted earnings per share were $12.29, compared with $10.57 in the third quarter of 2025.
  • Adjusted diluted EPS increased 13% to $12.57 from $11.15 in the prior-year period.
  • Full-year 2026 adjusted EPS is forecast to be between $47.70 and $47.90.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$1.09B+6.3% $12.29+16.3% $245.95M22.5%
Jun 2026$1.03B+4.5% $11.55+18.3% $232.90M22.7%
Mar 2026$947.13M+7.2% $8.33+6.7% $169.45M17.9%
Dec 2025$1.13B+8.1% $13.93+16.8% $285.76M25.3%
Sep 2025$1.03B+7.9% $10.57+6.1% $217.49M21.1%
Jun 2025$983.22M+3.9% $9.76-5.9% $202.35M20.6%
Mar 2025$883.74M-4.6% $7.81-5.2% $163.59M18.5%
Dec 2024$1.05B+11.8% $11.93+39.9% $252.30M24.1%

From Mettler Toledo's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$4.03B+4.0% $42.05+3.9%21.6%
FY2024$3.87B+2.2% $40.48+12.8%22.3%
FY2023$3.79B-3.4% $35.90-6.5%20.8%
FY2022$3.92B+5.4% $38.41+17.2%22.3%
FY2021$3.72B+20.5% $32.78+31.6%20.7%

Frequently asked questions

When is Mettler Toledo's next earnings date?

Mettler Toledo has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Mettler Toledo earn last quarter?

For the quarter ended Sep 2026, Mettler Toledo reported diluted EPS of $12.29 (+16.3% year over year) on revenue of $1.09B (+6.3%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.